Bronchial Smooth Muscle Cells of Asthmatics Promote Angiogenesis through Elevated Secretion of CXC-Chemokines (ENA-78, GRO-α, and IL-8)
Open Access
- 5 December 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (12), e81494
- https://doi.org/10.1371/journal.pone.0081494
Abstract
Airway wall remodelling is a key pathology of asthma. It includes thickening of the airway wall, hypertrophy and hyperplasia of bronchial smooth muscle cells (BSMC), as well as an increased vascularity of the sub-epithelial cell layer. BSMC are known to be the effector cells of bronchoconstriction, but they are increasingly recognized as an important source of inflammatory mediators and angiogenic factors. To compare the angiogenic potential of BSMC of asthmatic and non-asthmatic patients and to identify asthma-specific angiogenic factors. Primary BSMC were isolated from human airway tissue of asthmatic and non-asthmatic patients. Conditioned medium (CM) collected from BSMC isolates was tested for angiogenic capacity using the endothelial cell (EC)-spheroid in vitro angiogenesis assay. Angiogenic factors in CM were quantified using a human angiogenesis antibody array and enzyme linked immunosorbent assay. Induction of sprout outgrowth from EC-spheroids by CM of BSMC obtained from asthma patients was increased compared with CM of control BSMC (twofold, p < 0.001). Levels of ENA-78, GRO-α and IL-8 were significantly elevated in CM of BSMC from asthma patients (p < 0.05 vs. non-asthmatic patients). SB 265610, a competitive antagonist of chemokine (CXC-motif) receptor 2 (CXCR2), attenuated the increased sprout outgrowth induced by CM of asthma patient-derived BSMC. BSMC isolated from asthma patients exhibit increased angiogenic potential. This effect is mediated through the CXCR2 ligands (ENA78, GRO-α and IL-8) produced by BSMC. CXCR2 ligands may play a decisive role in directing the neovascularization in the sub-epithelial cell layers of the lungs of asthma patients. Counteracting the CXCR2-mediated neovascularization by pharmaceutical compounds may represent a novel strategy to reduce airway remodelling in asthma.Keywords
This publication has 50 references indexed in Scilit:
- Coaction of Spheroid-Derived Stem-Like Cells and Endothelial Progenitor Cells Promotes Development of Colon CancerPLOS ONE, 2012
- Effect of Bronchoconstriction on Airway Remodeling in AsthmaNew England Journal of Medicine, 2011
- A common intracellular allosteric binding site for antagonists of the CXCR2 receptorBritish Journal of Pharmacology, 2010
- VEGF and inhibitors of TGFβ type-I receptor kinase synergistically promote blood-vessel formation by inducing α5-integrin expressionJournal of Cell Science, 2009
- SB265610 is an allosteric, inverse agonist at the human CXCR2 receptorBritish Journal of Pharmacology, 2009
- Airway Smooth Muscle Growth in Asthma: Proliferation, Hypertrophy, and MigrationProceedings of the American Thoracic Society, 2008
- Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthmaThe Journal of Experimental Medicine, 2007
- Allergen-induced airway remodellingEuropean Respiratory Journal, 2007
- Atypical GPI-Anchored T-Cadherin Stimulates Angiogenesis In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Cancer CXC chemokine networks and tumour angiogenesisEuropean Journal Of Cancer, 2006